JACC: CardioOncology - Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients with Transthyretin Amyloid Cardiomyopathy
Episode Description
Commentary by Dr. Martha Grogan
We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies